1. Market Research
  2. > Diagnostics Market Trends
  3. > Molecular Imaging Agents: Targets, Technology, Markets, and Commercial Opportunities

Driven by advances in molecular probe design and biomarker detection methodologies, new imaging agents that can improve visualization of pathologies and cellular processes are changing the practice of diagnostic medicine. The ability of this new generation of contrast agents to detect metabolic changes at the molecular level has significant potential for improving visualization and quality of care. Targetable and activatable imaging agents are gaining interest for a wide range of diagnostic applications that include cardiology, neurology and soft tissue tumor detection. The number of healthcare conditions that can be effectively imaged noninvasively is expanding as a result of these innovative detection technologies. Targeted and activatable imaging agents offer a unique capability to generate unambiguous images by exploiting specific molecular targets, pathways or cellular processes. This new wave of imaging agents signals a paradigm shift in which the reagents take on new importance.

Highlights

· Analyzes and assesses emerging imaging diagnostic candidates, their capabilities, benefits, limitations and potential
· Profiles development-stage imaging agents and examines their clinical status and commercial prospects
· Analyzes key industry alliances and partnerships by imaging modality, and examines the impact of next-generation imaging candidates on future imaging markets
· Profiles market participants, their development activity and business strategies
· Evaluates the impact of economic, technology, and regulatory factors on the development and commercialization of emerging imaging agents

Table Of Contents

Molecular Imaging Agents: Targets, Technology, Markets, and Commercial Opportunities
Summary of Contents

Executive Summary

Diagnostic Imaging Market Dynamics

The Imaging Agent Landscape
Key Application Development Factors
Molecular Imaging Agent Marketspace
Commercial MIAs
Development Stage MIAs
Market Drivers
Industry Alignment and Competitive Landscape

Diagnostic Imaging Product Segment Analysis

Imaging Agent Product Segments and Commercial Potential
Antibodies
Conjugated Radioisotopes
Lanthanide Chelates
Metabolic Biomarkers
Optical Probes
Nanoparticles
Targeted Imaging Agents
Activatable Imaging Agents
Leading Academic/Research Programs/Centers

MIAs and Imaging Modalities - The Current Picture

MRI
Optical Imaging
PET
SPECT
Ultrasound

Evolution in Imaging Agent Market Segments

Disease Detection
Image-Guided Drug Delivery
Physiological Process Mapping
Therapeutic Screening
Treatment Assessment
Differential Diagnosis

MIAs in Healthcare - Clinical Applications

Physiological Visualization
Angiogenesis
Apoptosis
Inflammation
Neurology
Disease Detection and Therapeutic Management
Autoimmunity
Cardiology
Neurology
Oncology

Market Factors

Guidance, Rules and Regulations
Managed Care and Reimbursement
Academic and Private Sector RandD Programs
Alliances and Partnerships

Company Profiles

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

The 2016-2021 World Outlook for Imaging Agents

The 2016-2021 World Outlook for Imaging Agents

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for imaging agents across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

Global Radiopharmaceuticals Industry

Global Radiopharmaceuticals Industry

  • $ 4 950
  • Industry report
  • March 2015
  • by Global Industry Analysts

This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Segments: Diagnostic Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals. The report provides ...

Bracco S.p.A. - Strategic SWOT Analysis Review

Bracco S.p.A. - Strategic SWOT Analysis Review

  • $ 125
  • Industry report
  • February 2015
  • by Global Data

Bracco S.p.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT ...

Global Imaging Agents Market

September 2014 $ 4 950

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.